Treatment of hodgkins lymphoma

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) A61K 31/167 (2006.01) A61P 35/00 (2006.01) C07K 16/28 (2006.01) C12N 5/16 (2006.01)

Patent

CA 2682266

Compositions comprising CD80 antagonists and methods using these compositions are provided for the treatment of Hodgkins lymphoma. More particularly, the disclosed CD80 antagonists may be used to induce apoptosis or lysis of Hodgkins Reed-Sternberg (HRS) cells, or to inhibit HRS cell activities that promote tumor development or progression.

L'invention propose des compositions comportant des antagonistes CD80 et des procédés d'utilisation de ces compositions pour le traitement de la maladie de Hodgkin. Plus particulièrement, les antagonistes CD80 décrits peuvent être utilisés pour induire une apoptose ou une lyse de cellules de Hodgkin Reed-Sternberg (HRS) ou pour inhiber des activités de cellules HRS qui favorisent le développement ou la progression de tumeur.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of hodgkins lymphoma does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of hodgkins lymphoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of hodgkins lymphoma will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1857875

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.